General Information |
|
Product |
CD39 Antibody FITC |
Description |
FITC-Conjugated EctoNucleoside TriPhosphate Diphosphohydrolase 1 Antibody |
Verified Applications |
ELISA, IHC, IP, WB |
Host |
Rabbit |
Species Cross Reactivity |
Human, Mouse, Rat |
Immunogen |
Synthetic peptide taken within amino acid region 440-490 on human EctoNucleoside TriPhosphate Diphosphohydrolase 1. |
|
|
Quantity |
100 µg |
Volume |
200 µl |
Concentration |
0.5-1.5 µg/µl in antibody stabilization buffer |
Immunoglobulin |
IgG |
Form |
FITC-Conjugated |
Purification Method |
Immobilized antigen affinity chromatography |
Clonality |
Polyclonal |
Storage |
-20⁰C for long term storage |
|
|
ELISA |
1:50,000 |
Immunohistochemistry | 1:50-1:200 |
Immunoprecipitation |
1:200 |
Western Blot |
1:2,500-1:5,000 |
|
|
Uniprot # |
|
Overview |
In the nervous system, could hydrolyze ATP and other nucleotides to regulate purinergic neurotransmission. Could also be implicated in the prevention of platelet aggregation by hydrolyzing platelet-activating ADP to AMP. |
Molecular Function |
blood coagulation cell adhesion nucleobase-containing small molecule catabolic process |
Subcellular Location |
Membrane; Multi-pass membrane protein |
Expression |
Expressed primarily on activated lymphoid cells. Also expressed in endothelial tissues. Isoform 1 and isoform 3 are present in both placenta and umbilical vein, whereas isoform 2 is present in placenta only. |
Structure |
Belongs to the GDA1/CD39 NTPase family. |
Alternative Nomenclature |
ATPDase antibody CD 39 antibody CD39 antigen antibody Ecto apyrase antibody Ecto ATP diphosphohydrolase antibody Ecto-ATPase 1 antibody Ecto-ATPDase 1 antibody Ectonucleoside triphosphate diphosphohydrolase 1 antibody ENTPD1 antibody Lymphoid cell activation antigen antibody NTPDase 1 antibody SPG64 antibody |
Protein information supplied by UniProt.
Product | Note | Status | Price | |
---|---|---|---|---|
|
ENTP1-101AP | |||
|
PC-ENTP1 | |||
|
P-ENTP1 | |||
|
ENTP1-BIOTIN | |||
Display accessory details |
Select your currency:
(c) FabGennix International Inc.